Macular Hemorrhage as the First Manifestation of Leukemia
Diagnostics · 16.05.2026 · 16 (10) · 1518
DOI: 10.3390/diagnostics16101518 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 16.05.2026. Verfasst von Bogumiła Wójcik-Niklewska und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Ophthalmology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-514 Katowice, Poland. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Acute lymphoblastic leukemia (ALL) is a malignant neoplasm of the blood and bone marrow characterized by the uncontrolled proliferation of precursor cells of B- or T-lymphocyte lineage. Usually, the disease arises because of spontaneous mutations in bone marrow cells. Risk factors include genetic predisposition, exposure to ionizing radiation, prior chemotherapy or radiotherapy, and certain environmental factors. Clinical manifestations may include recurrent infections, anemia, and an increased tendency toward bleeding and stroke. A 12-year-old boy presented to the emergency department with a sudden decrease in visual acuity in the right eye. Best-corrected visual acuity (BCVA) in the right eye was 0.02, and intraocular pressure (IOP) was 16 mmHg. Ophthalmologic examination revealed a macular hemorrhage in the right eye. Blood samples were obtained for laboratory analysis. Complete blood count demonstrated leukocytosis with a white blood cell (WBC) count of 362.58 × 103/µL, thrombocytopenia with a platelet (PLT) count of 87 × 103/µL, hemoglobin (Hgb) level of 8.7 g/dL, and a red blood cell (RBC) count of 3.46 × 106/µL. The patient was subsequently referred to the Department of Pediatric Hematology, where the diagnosis of acute lymphoblastic leukemia of B-cell precursor origin was confirmed. Appropriate systemic therapy targeting the underlying disease was initiated.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Ophthalmology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-514 Katowice, Poland.
- Professor Kornel Gibiński University Hospital Center, Medical University of Silesia, 40-514 Katowice, Poland.
- Students' Scientific Society, Department of Ophthalmology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-752 Katowice, Poland.
- GlaucoTech Co., Ltd., 40-282 Katowice, Poland.
ORCID-Profile: Bogumiła Wójcik-Niklewska, Natalia Kwasniewska, Adrian Smędowski
Zitieren
APA
Wójcik-Niklewska, B., Kwasniewska, N., & Smędowski, A. (2026). Macular Hemorrhage as the First Manifestation of Leukemia. Diagnostics, 16(10), 1518. https://doi.org/10.3390/diagnostics16101518
Vancouver
Wójcik-Niklewska B, Kwasniewska N, Smędowski A. Macular Hemorrhage as the First Manifestation of Leukemia. Diagnostics. 2026;16(10):1518. doi:10.3390/diagnostics16101518
BibTeX
@article{WjcikNiklewska2026,
author = {Wójcik-Niklewska, Bogumiła and Kwasniewska, Natalia and Smędowski, Adrian},
title = {Macular Hemorrhage as the First Manifestation of Leukemia},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {10},
pages = {1518},
doi = {10.3390/diagnostics16101518}
}
EUVIMED